Immuno-oncology drug development forges on despite COVID-19

Nat Rev Drug Discov. 2020 Nov;19(11):751-752. doi: 10.1038/d41573-020-00166-1.
No abstract available

Publication types

  • News

MeSH terms

  • Allergy and Immunology / trends*
  • COVID-19
  • Clinical Trials as Topic / statistics & numerical data
  • Coronavirus Infections*
  • Drug Development
  • Humans
  • Medical Oncology / trends*
  • Neoplasms / therapy*
  • Pandemics*
  • Pneumonia, Viral*